Results 131 to 140 of about 2,232,302 (267)
Judicialization and right to health in Brazil: a trajectory of matches and mismatches. [PDF]
Vieira FS.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Bridging the gap between economic regulation and the right to health: a study on renewable energy, financial inclusion, and under-5 mortality in EU administrative contexts. [PDF]
Ning X, Arshad R.
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Advancing the human right to health in cancer care through drug repurposing strategies. [PDF]
Sakis N +3 more
europepmc +1 more source
Economic sanctions, healthcare and the right to health. [PDF]
Germani F +3 more
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Front-of-package labelling: A public health imperative rooted in the right to health. [PDF]
Radu YT, Mahomedy S.
europepmc +1 more source

